Search results for "Bone disease"

showing 10 items of 119 documents

Treatment of multiple myeloma-related bone disease

2021

In this Policy Review, the Bone Working Group of the International Myeloma Working Group updates its clinical practice recommendations for the management of multiple myeloma-related bone disease. After assessing the available literature and grading recommendations using the Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) method, experts from the working group recommend zoledronic acid as the preferred bone-targeted agent for patients with newly diagnosed multiple myeloma, with or without multiple myeloma-related bone disease. Once patients achieve a very good partial response or better, after receiving monthly zoledronic acid for at least 12 months, the treating…

0301 basic medicinemedicine.medical_specialtyBone Density Conservation AgentBone disease03 medical and health sciences0302 clinical medicineSpinal cord compressionmedicineHumansMultiple myelomaBone Density Conservation Agentsbusiness.industrymedicine.diseaseSurgeryDiscontinuationTransplantationBone Density Conservation Agents030104 developmental biologyZoledronic acidDenosumabOncology030220 oncology & carcinogenesisPractice Guidelines as TopicBone DiseasesbusinessBone DiseaseMultiple Myelomamedicine.drugHumanThe Lancet Oncology
researchProduct

Myeloma-Induced Alterations of Glutamine Metabolism Impair Bone Microenvironment Niche in Multiple Myeloma Patients

2018

Abstract Multiple myeloma (MM) cells are characterized by tight dependence on the bone marrow (BM) microenvironment that exerts a permissive role on cell growth and survival. In turn, MM cells markedly modify their microenvironment leading, in particular, to the development of osteolytic bone lesions. Recently, we demonstrated that metabolic alterations is a major feature of MM cells showing that BM plasma of MM patients is characterized by lower levels of Glutamine (Gln) and higher levels of Glutamate (Glu) and ammonium when compared with patients with smoldering MM (SMM) and Monoclonal Gammopathy of Uncertain Significance (MGUS). In the majority of MM patients MM cells are Gln-addicted si…

0301 basic medicinemedicine.medical_specialtyStromal cellBone diseaseChemistryImmunologyCell BiologyHematologymedicine.disease030226 pharmacology & pharmacyBiochemistryGlutamine03 medical and health sciences030104 developmental biology0302 clinical medicineEndocrinologymedicine.anatomical_structureCell cultureGlutamine synthetaseInternal medicineBone cellmedicineBone marrowMonoclonal gammopathy of undetermined significanceBlood
researchProduct

Consensus Document on substitution therapy with DHEA in the elderly

2006

AdultMaleAgingmedicine.medical_specialtyHormone Replacement TherapyAlternative medicineSocio-culturaleAdult; Aged; Aged 80 and over; Aging; Atherosclerosis; Bone Diseases Metabolic; Cognition Disorders; Dehydroepiandrosterone; Female; Hormone Replacement Therapy; Humans; Italy; Male; Middle Aged80 and overAdrenal insufficiencyHumansMedicineSubstitution therapyIntensive care medicineAgedAged 80 and overbusiness.industryGeriatrics gerontologyDehydroepiandrosteroneMiddle AgedAtherosclerosismedicine.diseaseConsensus Document elderly adrenal insufficiency adrenopause DHEA DHEAS DHEA substitution therapyBone Diseases MetabolicItalyPhysical therapyFemaleMetabolicBone DiseasesGeriatrics and GerontologyCognition DisordersbusinessAging Clinical and Experimental Research
researchProduct

HETEROGENEITY OF METATROPIC DYSPLASIA

1983

Metatropic dysplasia is a neonatally manifest entity that is characterized clinically by a rapidly progressing kyphoscoliosis leading to severe shortening of the originally long trunk ("metatropism"). Major radiographic features include flattening and defective ossification of the vertebral bodies, a narrow thorax and a marked hypoplasia of the basilar portions of the ilia with crescent-shaped iliac crests. There is some evidence of genetic heterogeneity. From five personal observations and from a review of the literature we conclude that metatropic dysplasia comprises at least three genetic entities: (1) a nonlethal type with autosomal recessive transmission; (2) a nonlethal dominant type …

AdultMalePathologymedicine.medical_specialtyDwarfismDwarfismShort staturemedicineHumansKyphosisChildKyphoscoliosisBone Diseases DevelopmentalGenetic heterogeneityOssificationbusiness.industryAnatomymedicine.diseaseOsteochondrodysplasiaTrunkHypoplasiaScoliosisPediatrics Perinatology and Child HealthFemalemedicine.symptombusiness
researchProduct

Metabolic Evaluation of 94 Patients 5 to 16 Years After Ileocecal Pouch (Mainz Pouch 1) Continent Urinary Diversion

2003

PURPOSE In continent urinary diversion metabolic disturbances may be encountered in long-term followup. We evaluated metabolic consequences in patients with a minimum followup of 5 years after Mainz pouch 1 urinary diversion.At our institution continent urinary diversion using the ileocecal segment was performed between 1983 and 1995 in 458 patients. A total of 94 patients with an ileocecal pouch for a minimum of 5 years were reevaluated for metabolic changes. Median followup was 9.0 years. Routine laboratory parameters, blood gas analysis, vitamin B12, vitamin D25, cross-laps, bone specific alkaline phosphatase, osteocalcin and propeptide of type I collagen were obtained. Bone density was …

AdultMalePhosphopeptidesmedicine.medical_specialtyBone diseaseBone densityUrologymedicine.medical_treatmentUrinary systemOsteocalcinOsteoporosisSodium CitratePostoperative ComplicationsCalcitriolBone DensityReference ValuesPotassium CitrateHumansMedicineCitratesMegaloblastic anemiaAgedbusiness.industryUrinary Reservoirs ContinentUrinary diversionMiddle AgedAlkaline Phosphatasemedicine.diseaseSurgeryVitamin B 12FemaleCollagenBlood Gas AnalysisPouchAcidosisEnergy MetabolismbusinessContinent Urinary DiversionProcollagenFollow-Up StudiesJournal of Urology
researchProduct

Outcome of enzyme replacement therapy in patients with Gaucher disease type I. The Romanian experience

2007

This study reports the first evaluation of therapeutic response in Romanian patients with Gaucher disease type I, after therapy with Cerezyme recently became available in our country.24 patients (11-50 years) received Cerezyme 20-60 U/kg every two weeks for at least 18 months. Haemoglobin, platelet count, volume of the liver and spleen, plasma chitotriosidase and the severity score were assessed every 6 months; skeletal radiography and osteodensitometry were also monitored.Eleven patients were splenectomized before start of therapy. Eight patients had anaemia (mean haemoglobin 9.4 g/dl) and 14 patients, of whom 13 were without splenectomy, had thrombocytopenia (mean 65,692/mm3). Haemoglobin…

AdultMalecongenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_specialtyPediatricsTime FactorsAdolescentBone diseasemedicine.medical_treatmentDiseaseWeight GainSeverity of Illness IndexHemoglobinsGeneticsmedicineHumansIn patientChildGenetics (clinical)ChemotherapyGaucher DiseasePlatelet CountRomaniabusiness.industryLiver DiseasesRomaniannutritional and metabolic diseasesAnemiaEnzyme replacement therapyMiddle Agedmedicine.diseaseCombined Modality TherapyThrombocytopeniaRecombinant Proteinslanguage.human_languageSurgeryHexosaminidasesTreatment OutcomeSplenomegalyQuality of LifeSplenectomylanguageGlucosylceramidaseFemaleBone DiseasesbusinessFollow-Up StudiesJournal of Inherited Metabolic Disease
researchProduct

Role of FNAC in the diagnosis of intraosseous jaw lesions

2014

Background: FNAC of intraosseous jaw lesions has not been widely utilized for diagnosis due to rarity and diversity of these lesions, limited experience and lack of well established cytological features. Aim of the study was to determine the role of FNAC in the diagnosis of intraosseous jaw swellings. Material and Methods: 42 patients underwent FNAC over a period of 7 years (2007-2013), of which 37 (88.1%) aspirates were diagnostic. Histopathology correlation was available in 33 cases and diagnostic accuracy of FNAC was calculated. Results: Lesions were categorized into inflammatory 3, cysts/hamartomas 15 and neoplasms 19. Mandibular and maxillary involvement was seen in 21 and 16 patients …

AdultMalemedicine.medical_specialtyAdolescentBiopsy Fine-NeedleOdontologíaOdontogenic cystCytologyBiopsymedicineHumansskin and connective tissue diseasesChildAmeloblastomaGeneral DentistryAgedRetrospective StudiesOral Medicine and Pathologymedicine.diagnostic_testbusiness.industryResearchRetrospective cohort studyMiddle Aged:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseCiencias de la saludOdontogenicSurgerybody regionsOtorhinolaryngologyChild PreschoolUNESCO::CIENCIAS MÉDICASFemaleSurgeryHistopathologyBone DiseasesJaw DiseasesbusinessJaw DiseasesMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Otoneurological management of petrous apex cholesterol granuloma

2009

Objective: The aim of the study is to review the management of petrous apex cholesterol granuloma. The surgical approaches for drainage or total removal and the wait and see policy were analyzed, and outcomes were evaluated. Methods: Retrospective charts of 27 patients managed for petrous apex cholesterol granuloma with a minimum follow-up of 12 months were analyzed in a quartenary skull base center. Presenting symptoms and signs were recorded, and radiologic imaging was evaluated. Management options included wait and see policy and surgery by several approaches. Results: The mean age of patients affected by the lesion was 38.8 years. The mean follow-up was 56.7 months. Patients complained …

AdultMalemedicine.medical_specialtyAdolescentEpidermal CystDiagnosis DifferentialYoung AdultTrigeminal neuralgiaVertigomedicine.arterymedicineHumansChildpetrous apexRetrospective StudiesDiplopiabiologyPetrous Apexbusiness.industryGranuloma Foreign-Bodycholesterol granulomaInfratemporal fossaskull baseMiddle Agedmedicine.diseasebiology.organism_classificationMagnetic Resonance ImagingSurgeryArachnoid Cystsmedicine.anatomical_structureCholesterolTreatment OutcomeOtorhinolaryngologyDrainageFemaletemporal bonemedicine.symptomInternal carotid arteryBone DiseasesbusinessTomography X-Ray ComputedTinnitusHemifacial spasmFollow-Up StudiesPetrous Bone
researchProduct

The craniocervical junction following successful haematopoietic stem cell transplantation for mucopolysaccharidosis type I H (Hurler syndrome)

2010

Mucopolysaccharidosis I Hurler (MPS IH) is a progressive multisystemic disorder caused by alpha-L-iduronidase deficiency. First choice of treatment in MPS IH children is haematopoietic stem cell transplantation (HSCT). The effect of HSCT has been shown to have limited influence on skeletal manifestations by poor penetration of musculoskeletal tissues by the enzyme derived from donor leucocytes. Aim of this study was to investigate the effect of HSCT on the craniocervical junction (CCJ) in Hurler patients. We analysed retrospectively sequential magnetic resonance imaging (MRI) scans of 30 patients with Hurler disease treated by HSCT since 1982 at the Royal Manchester Children's Hospital, UK,…

AdultMalemedicine.medical_specialtyAdolescentMucopolysaccharidosis Imedicine.medical_treatmentHematopoietic stem cell transplantationCohort StudiesYoung AdultMucopolysaccharidosis type IMucopolysaccharidosis IGeneticsmedicineHumansChildHurler syndromeGenetics (clinical)Retrospective StudiesBone Diseases Developmentalbusiness.industryOdontoid HypoplasiaSkullHematopoietic Stem Cell TransplantationBrainmedicine.diseaseMagnetic Resonance ImagingHypoplasiaSurgeryRadiographyTransplantationTreatment OutcomeGraft-versus-host diseaseChild PreschoolFemalebusinessJournal of Inherited Metabolic Disease
researchProduct

The value of nuclear medicine for the diagnosis of spine diseases.

1993

Nuclear medicine examinations hold an important position in the diagnosis of diseases of the spine. During the last decade, decisive progress has been made in the field of instrumentation and radiopharmaceutical techniques: the use of high resolution collimators and the introduction of emission computer tomography as examples of improved instrumentation as well as 99m-Technetium red blood cell labelling as a new radiopharmaceutical technique. These present some of the developments responsible for the growing importance of scintigraphical diagnosis. Inflammatory processes of the vertebrae and the surrounding soft tissues can be detected or excluded with high reliability by the use of radionu…

AdultMalemedicine.medical_specialtyBone diseaseScintigraphyBone and BonesBone remodelingPredictive Value of TestsmedicineHumansRadionuclide AngiographyAgedSpinal Neoplasmsmedicine.diagnostic_testbusiness.industrySoft tissueMagnetic resonance imagingGeneral MedicineMiddle Agedmedicine.diseasemedicine.anatomical_structureBone scintigraphyChild PreschoolOsteoporosisSurgeryFemaleSpinal DiseasesNeurology (clinical)RadiologyDifferential diagnosisbusinessNuclear medicineVertebral columnSpondylitisNeurosurgical review
researchProduct